Ident. | Authors (with country if any) | Title |
---|
000815 |
Dianbo Qu ; Ali Hage ; Katie Don-Carolis ; En Huang ; Alvin Joselin ; Farzaneh Safarpour ; Paul C. Marcogliese ; Maxime W. C. Rousseaux ; Sarah J. Hewitt ; Tianwen Huang ; Doo-Soon Im ; Steve Callaghan ; Danielle Dewar-Darch [Canada] ; Daniel Figeys [Canada] ; Ruth S. Slack ; David S. Park | BAG2 Gene-mediated Regulation of PINK1 Protein Is Critical for Mitochondrial Translocation of PARKIN and Neuronal Survival* |
000875 |
Gonzalo Sanchez [Canada] ; Rafael K. Varaschin [Canada] ; Hansruedi Büeler [République populaire de Chine] ; Paul C. Marcogliese [Canada] ; David S. Park [Canada] ; Louis-Eric Trudeau [Canada] | Unaltered Striatal Dopamine Release Levels in Young Parkin Knockout, Pink1 Knockout, DJ-1 Knockout and LRRK2 R1441G Transgenic Mice |
000947 |
Mohammad Parsanejad ; Yi Zhang ; Dianbo Qu ; Isabella Irrcher [Canada] ; Maxime W C. Rousseaux ; Hossein Aleyasin ; Fatemeh Kamkar ; Steve Callaghan ; Ruth S. Slack ; Tak W. Mak ; Stephen Lee ; Daniel Figeys [Canada] ; David S. Park [Canada] | Regulation of the VHL/HIF-1 pathway by DJ-1. |
000B10 |
Mohammad Parsanejad [Canada] ; Noam Bourquard [États-Unis] ; Dianbo Qu [Canada] ; Yi Zhang [Canada] ; En Huang [Canada] ; Maxime W. C. Rousseaux [Canada, États-Unis] ; Hossein Aleyasin [Canada, États-Unis] ; Isabella Irrcher [Canada] ; Steve Callaghan [Canada] ; Dominique C. Vaillant [Canada] ; Raymond H. Kim [Canada] ; Ruth S. Slack [Canada] ; Tak W. Mak [Canada] ; Srinivasa T. Reddy [États-Unis] ; Daniel Figeys [Canada] ; David S. Park [Canada, Corée du Sud] | DJ-1 Interacts with and Regulates Paraoxonase-2, an Enzyme Critical for Neuronal Survival in Response to Oxidative Stress |
001146 |
Katerina Venderova [États-Unis] ; David S. Park [Canada] | Programmed Cell Death in Parkinson's Disease |
001401 |
Andrew W. Greene [Canada] ; Karl Grenier [Canada] ; Miguel A. Aguileta [Canada] ; Stephanie Muise [Canada] ; Rasoul Farazifard [Canada] ; M Emdadul Haque [Canada] ; Heidi M. Mcbride [Canada] ; David S. Park [Canada] ; Edward A. Fon [Canada] | Mitochondrial processing peptidase regulates PINK1 processing, import and Parkin recruitment |
001496 |
Maria Xilouri [Grèce] ; Elli Kyratzi [Grèce] ; Pothitos M. Pitychoutis [Grèce] ; Zoi Papadopoulou-Daifoti [Grèce] ; Celine Perier [Espagne] ; Miquel Vila [Espagne] ; Matina Maniati [Grèce] ; Ayse Ulusoy [Suède] ; Deniz Kirik [Suède] ; David S. Park [Canada] ; Keiji Wada [Japon] ; Leonidas Stefanis [Grèce] | Selective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system |
001500 |
Alvin P. Joselin [Canada] ; Sarah J. Hewitt [Canada] ; Steve M. Callaghan [Canada] ; Raymond H. Kim [Canada] ; Young-Hwa Chung [Corée du Sud] ; Tak W. Mak [Canada] ; JIE SHEN [États-Unis] ; Ruth S. Slack [Canada] ; David S. Park [Canada, Corée du Sud] | ROS-dependent regulation of Parkin and DJ-1 localization during oxidative stress in neurons |
001618 |
Mansoureh Hakimi [Canada] ; Thirumahal Selvanantham [Canada] ; Erika Swinton [Canada] ; Ruth F. Padmore [Canada] ; Youren Tong [États-Unis] ; Ghassan Kabbach [Canada] ; Katerina Venderova [Canada] ; Stephen E. Girardin [Canada] ; Dennis E. Bulman [Canada] ; Clemens R. Scherzer [États-Unis] ; Matthew J. Lavoie [États-Unis] ; Denis Gris [États-Unis] ; David S. Park [Canada] ; Jonathan B. Angel [Canada] ; Jie Shen [États-Unis] ; Dana J. Philpott [Canada] ; Michael G. Schlossmacher [Canada] | Parkinson’s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures |
001994 |
Subhas C. Biswas [États-Unis] ; Yi Zhang [Canada] ; Grace Iyirhiaro [Canada] ; Ryan T. Willett [États-Unis] ; Yasmilde Rodriguez Gonzalez [Canada] ; Sean P. Cregan ; Ruth S. Slack [Canada] ; David S. Park [Canada] ; Lloyd A. Greene [États-Unis] | SERTAD1 PLAYS AN ESSENTIAL ROLE IN DEVELOPMENTAL AND PATHOLOGICAL NEURON DEATH |
001A70 |
Hossein Aleyasin [Canada] ; Maxime W. C. Rousseaux [Canada] ; Paul C. Marcogliese [Canada] ; Sarah J. Hewitt [Canada] ; Isabella Irrcher [Canada] ; Alvin P. Joselin [Canada] ; Mohammad Parsanejad [Canada] ; Raymond H. Kim [Canada] ; Patrizia Rizzu [Pays-Bas] ; Steve M. Callaghan [Canada] ; Ruth S. Slack [Canada] ; Tak W. Mak [Canada] ; David S. Park [Canada, Corée du Sud] | DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway |
001B52 |
En Huang [Canada] ; Dianbo Qu [Canada] ; Yi Zhang [Canada] ; Katerina Venderova [Canada] ; M. Emdadul Haque [Canada] ; Maxime W. C. Rousseaux [Canada] ; Ruth S. Slack [Canada] ; John M. Woulfe [Canada] ; David S. Park [Canada, Corée du Sud] | The role of Cdk5-mediated apurinic/apyrimidinic endonuclease 1 phosphorylation in neuronal death |
001D99 |
Isabella Irrcher [Canada] ; David S. Park | Parkinson's disease: to live or die by autophagy. |
001F19 |
Katerina Venderova ; Ghassan Kabbach ; Elizabeth Abdel-Messih ; Yi Zhang ; Robin J. Parks ; Yuzuru Imai ; Stephan Gehrke ; Johnny Ngsee ; Matthew J. Lavoie ; Ruth S. Slack ; Yong Rao [Canada] ; Zhuohua Zhang [États-Unis] ; Bingwei Lu ; M. Emdadul Haque [Canada] ; David S. Park [Canada] | Leucine-rich repeat kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson's disease |
002209 |
M. Emdadul Haque [Canada] ; Kelly J. Thomas [États-Unis] ; Cheryl D'Souza [Canada] ; Steve Callaghan [Canada] ; Tohru Kitada [États-Unis] ; Ruth S. Slack [Canada] ; Paul Fraser [Canada] ; Mark R. Cookson [États-Unis] ; Anurag Tandon [Canada] ; David S. Park [Canada] | Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP |
002430 |
Hossein Aleyasin [Canada] ; Maxime W. C. Rousseaux [Canada] ; Maryam Phillips [Canada] ; Raymond H. Kim [Canada] ; Ross J. Bland [États-Unis] ; Steve Callaghan [Canada] ; Ruth S. Slack [Canada] ; Matthew J. During [États-Unis] ; Tak W. Mak [Canada] ; David S. Park [Canada] | The Parkinson's disease gene DJ-1 is also a key regulator of stroke-induced damage |
002440 |
Dianbo Qu [Canada] ; Juliet Rashidian ; Matthew P. Mount ; Hossein Aleyasin ; Mohammad Parsanejad ; Arman Lira ; Emdadul Haque ; Yi Zhang ; Steve Callaghan ; Mireille Daigle ; Maxime W C. Rousseaux ; Ruth S. Slack ; Paul R. Albert ; Inez Vincent ; John M. Woulfe ; David S. Park | Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease. |
002466 |
Matthew P. Mount [Canada] ; Arman Lira ; David Grimes ; Patrice D. Smith ; Sylvie Faucher ; Ruth Slack ; Hymie Anisman ; Shawn Hayley ; David S. Park | Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons. |
002980 |
Raymond H. Kim [Canada] ; Patrice D. Smith [Canada] ; Hossein Aleyasin [Canada] ; Shawn Hayley [Canada] ; Matthew P. Mount [Canada] ; Scott Pownall [Canada] ; Andrew Wakeham [Canada] ; Annick J. You-Ten [Canada] ; Suneil K. Kalia [Canada] ; Patrick Horne [Canada] ; David Westaway [Canada] ; Andres M. Lozano [Canada] ; Hymie Anisman [Canada] ; David S. Park [Canada] ; Tak W. Mak [Canada] | Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress |
002B18 |
Wiplove Lamba [Canada] ; Wendy Prichett [Canada] ; David Munoz [Canada] ; David S. Park [Canada] ; John M. Woulfe [Canada] | MPTP induces intranuclear rodlet formation in midbrain dopaminergic neurons |
002B94 |
Patrice D. Smith [Canada] ; Michael J. O'Hare ; David S. Park | CDKs: taking on a role as mediators of dopaminergic loss in Parkinson's disease. |
002B96 |
Suneil K. Kalia [Canada] ; Sang Lee ; Patrice D. Smith ; Li Liu ; Stephen J. Crocker ; Thorhildur E. Thorarinsdottir ; John R. Glover ; Edward A. Fon ; David S. Park ; Andres M. Lozano | BAG5 inhibits parkin and enhances dopaminergic neuron degeneration. |
002D79 |
Stephen J. Crocker [Canada] ; Patrice D. Smith ; Vernice Jackson-Lewis ; Wiplore R. Lamba ; Shawn P. Hayley ; Erich Grimm ; Steve M. Callaghan ; Ruth S. Slack ; Edon Melloni ; Serge Przedborski ; George S. Robertson ; Hymie Anisman ; Zul Merali ; David S. Park | Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. |
002D89 |
Patrice D. Smith [Canada] ; Stephen J. Crocker [Canada] ; Vernice Jackson-Lewis ; Kelly L. Jordan-Sciutto [États-Unis] ; Shawn Hayley [Canada] ; Matthew P. Mount [Canada] ; Michael J. O'Hare [Canada] ; Steven Callaghan [Canada] ; Ruth S. Slack [Canada] ; Serge Przedborski [États-Unis] ; Hymie Anisman [Canada] ; David S. Park [Canada] | Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease |
003200 |
Stephen J. Crocker ; Nichola Wigle [Canada] ; Peter Liston [Canada] ; Charlie S. Thompson ; Chris J. Lee [Canada] ; Daigen Xu ; Sophie Roy [Canada] ; Donald W. Nicholson [Canada] ; David S. Park ; Alex Mackenzie [Canada] ; Robert G. Korneluk [Canada] ; George S. Robertson [Canada] | NAIP protects the nigrostriatal dopamine pathway in an intrastriatal 6‐OHDA rat model of Parkinson's disease |